We’ve had a great #Tandem24 so far!
3 CIBMTR Working Committee proposals presented ✅ presented by Tommy Alfaro Moya and Niranjan Khaire
Outcomes of VDPACE in RRMM, excellent learning opportunity ASTCT #Tandem24 and mentorship from Leyla Shune MD, Al-Ola A Abdallah MD (USMIRC), Nausheen Ahmed MD, Shebli Atrash Hamza Hashmi Muhammad Umair Mushtaq (Abu Mikael)
Our colleague Niranjan Khaire presenting the joint proposal regarding the outcomes of patients with aplastic anemia lacking a MSD undergoing alloHCT with PTCY as GVHD prophylaxis
Hans Messner Allogeneic BMT Program Moffitt Cancer Center #Tandem24
Former co-fellows Yale Hematology Oncology Fellows and future collaborators ASTCT #Tandem24 . Looking forward to a collaboration between Moffitt Cancer Center and Fred Hutchinson Cancer Center.
Visit poster 510. aroog 💌 presenting : Outcomes of pts progressing after BCMA CART therapy. What does the data show ? ASTCT #Tandem24 Al-Ola A Abdallah MD (USMIRC) Hamza Hashmi 👇👇👇
Congrats to Nima Ghalehsari, MD presenting his work on Impact of Graft Source on Transplant Outcomes for pts with Myelofibrosis. #Tandem24
NewYork-Presbyterian Weill Cornell BMT Program
Let’s talk about Global Access to Myeloma Immune Effector Cell Therapy ( GLAMM-1) survey by Al-Ola A Abdallah MD (USMIRC) USMIRC News . Stellar KU Cancer Center Emerson Logan presenting our findings ASTCT #Tandem24
A Prospective Study of Tocilizumab for the Prevention of Graft Failure and GVHD in Haplo-Cord Transplantation, as a Potential Alternative to Anti-Thymocyte Globulin
Nina Orfali Mohammad Alhomoud Weill Cornell Medicine Weill Cornell MedicineBMT #Tandem24